The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial

BACKGROUND: Fully efficient vaccines against malaria pre-erythrocytic stage are still lacking. The objective of this dose/adjuvant-finding study was to evaluate the safety, reactogenicity and immunogenicity of a vaccine candidate based on a peptide spanning the C-terminal region of Plasmodium falcip...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Audran, Régine, Lurati-Ruiz, Floriana, Genton, Blaise, Blythman, Hildur E., Ofori-Anyinam, Opokua, Reymond, Christophe, Corradin, Giampietro, Spertini, François
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2009
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2749339/
https://ncbi.nlm.nih.gov/pubmed/19798415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0007304
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak